Shares of Vir Biotechnology (CIR) climbed ~42% in the premarket on Wednesday after the company posted initial Phase 1 data ...

Toyota’s futuristic city, designed for up to 2,000 residents, reached its first milestone with sustainable innovations like ...

The first MAPS 4 bus stop improvements are complete and open for service in northeast Oklahoma City.According to the City of Oklahoma City, the project will imp ...

Phase 1 of the project will focus on the construction of a parking deck downtown. Phase 2 will include apartments, retail and ...

Vision Net, a leading provider of network and technology solutions for carriers, enterprise businesses, healthcare organizations, and educational institutions, announced a series of significant ...

With an aggregate of $11 million raised in an initial Series A funding round, Doron Therapeutics is advancing its lead ...

Neumora's KOASTAL-1 study results show navacaprant missed key goals in major depressive disorder. Additional studies and ...

Suven Life Sciences surged 9.51% to Rs 138.70 after the firm dosed first subjects in a Phase-1 clinical trial of SUVN-I6107 being conducted in USA under FDA acceptance of investigational new drug (IND ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Immuneering (IMRX) announced a positive data update from three pancreatic cancer arms of its ongoing Phase 2a trial of lead program IMM-1-104, ...